Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
ID: 358824Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358824
Timeline
    Description

    The National Institutes of Health (NIH) is offering a limited competition grant opportunity titled "Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03)," aimed at enhancing the research capabilities of early-career scientists supported by NIAMS. This program is specifically designed for recipients of K awards who are in the second to fourth year of their funding, allowing them to apply for R03 support to conduct small, self-contained research projects, pilot studies, or develop new research methodologies, with the stipulation that clinical trials are not permitted. Interested applicants should note that while applications are not currently being solicited, they are encouraged to prepare for the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis posting date of August 20, 2025, and a closing date of October 20, 2025. For further inquiries, potential applicants can contact Su-Yau Mao, Ph.D., at su-yau.mao@nih.gov or by phone at 301-451-1945.

    Point(s) of Contact
    Su-Yau Mao, Ph.D.
    (301) 451-1945
    su-yau.mao@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition Small Grant Program aimed at recipients of specific NIDDK career development awards (K01, K08, K23, K25) to support their research during the latter years of their awards. This program is designed to enhance the transition to independent research by allowing these recipients to conduct pilot studies, secondary analyses, and other small projects, which are crucial for generating publications and data necessary for future R01 applications. The grant provides direct costs of up to $75,000 per year for a maximum of two years, with applications required to include a Plan for Enhancing Diverse Perspectives (PEDP) as part of the review process. Interested applicants should note that the submission period opens on January 16, 2025, with subsequent deadlines through January 2028, and can direct inquiries to grantsinfo@nih.gov for further information.
    Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), has announced a Limited Competition Small Grant Program aimed at supporting current and recently completed K01, K08, K23, and K25 award recipients. This funding opportunity, designated as RFA-HL-25-011, allows eligible applicants to secure up to $75,000 per year for projects lasting up to two years, with the goal of generating preliminary data for subsequent R01-equivalent applications. The program is particularly focused on advancing early-stage investigators towards independent research careers, emphasizing the inclusion of underrepresented groups in biomedical research. Interested applicants must adhere to strict submission guidelines via Grants.gov, with a close date for applications set for January 7, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition Small Grant Program (R03) aimed at supporting current or recently completed NHLBI K01, K08, K23, and K25 awardees in enhancing their research capabilities as they transition to independent investigator roles. This funding opportunity allows eligible applicants to receive up to $75,000 per year for short-term research projects that can be completed within two years, focusing on activities such as pilot studies, proof of concept evaluations, and methodological development that generate preliminary data for future R01 applications. The program emphasizes the importance of fostering a diverse scientific workforce and is open for applications from January 13, 2023, with a closing date of January 7, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 recipients, aimed at supporting those who have completed the first two years of their award. This program, identified as PAR-25-176, seeks to enhance the research capabilities of SERCA K01 awardees as they transition to independent investigator status, focusing on projects such as pilot studies, feasibility studies, and methodology development, while explicitly excluding clinical trial applications. Each project may receive up to $75,000 in direct costs over a two-year period, with applications encouraged from a diverse range of eligible organizations, including higher education institutions and community-based organizations. Interested applicants should note that the application deadline is May 7, 2026, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition Small Grant Program aimed at supporting recipients of the Special Emphasis Research Career Award (SERCA) K01 who have completed the first two years of their award. This program provides funding of up to $75,000 in direct costs over a maximum period of two years to facilitate small-scale research projects, excluding clinical trials, thereby assisting awardees in transitioning to independent research roles. The initiative is part of NIH's commitment to enhancing the diversity of research talent and advancing biomedical research, particularly in veterinary science. Interested applicants from eligible organizations must adhere to submission guidelines, with applications accepted until May 7, 2026; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-127.html.
    NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering funding through the Small Research Grant Program (Parent R03 Clinical Trial Not Allowed), aimed at supporting discrete research projects that can be completed within two years and require limited resources. This program encourages applications for various types of research, including pilot studies, feasibility studies, and the development of new research methodologies, while explicitly excluding clinical trials. With a funding ceiling of $50,000 per year, the program is open to a diverse range of eligible applicants, including higher education institutions, nonprofits, and government entities, particularly those representing historically underrepresented groups. Interested applicants should note that the first submission opportunity opens on January 16, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program, designated as R03 Clinical Trial Optional. This funding opportunity aims to support KL2/K12 scholars and recipients of diversity and re-entry supplements in their transition to independent research roles by funding small, innovative, self-contained projects in translational science, with a maximum budget of $50,000 per year over a two-year period. The initiative is designed to enhance the capabilities of emerging researchers in addressing inefficiencies in translating research into clinical applications, engaging underrepresented populations, and improving data accessibility through innovative technologies. Applications will be accepted starting January 19, 2024, with multiple deadlines leading up to October 20, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Center for Advancing Translational Sciences (NCATS), has announced a funding opportunity for the Limited Competition Small Grant Program (R03), aimed at supporting Clinical and Translational Science Award (CTSA) Program KL2/K12 scholars and diversity supplement recipients. This program is designed to facilitate the transition of these scholars to independent research careers by funding small, self-contained research projects that can be conducted quickly and with limited resources, ultimately addressing inefficiencies in translational science. Grants of up to $50,000 per year are available for projects lasting up to two years, with a submission deadline of January 17, 2025, and an anticipated award cycle beginning in February 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Small Grant Program for NHLBI Career Development Recipients (Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a Limited Competition Small Grant Program aimed at NHLBI Career Development recipients, with the option for clinical trials. This funding opportunity is designed to support current or recently completed NHLBI career development awardees in expanding their research objectives or initiating new studies stemming from their previous work, particularly to assist those transitioning to research independence. The program is crucial for generating preliminary data and publications that facilitate the transition from K-awards to R-awards. While applications are not currently being solicited, interested investigators are encouraged to prepare for future submissions, with the estimated synopsis posting date set for March 1, 2026, and a projected award date of October 1, 2026. For further inquiries, potential applicants can contact the NHLBI at nhlbidldgrants@nhlbi.nih.gov.
    Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing an upcoming funding opportunity titled "Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)," aimed at supporting research that leverages resources from ongoing clinical studies. This initiative encourages applications for ancillary studies that utilize well-characterized patient cohorts, infrastructure, data, and biological samples, while aligning with the mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). With an estimated total program funding of $600,000 and the expectation of awarding two grants, potential applicants are advised to begin developing collaborations and project proposals in advance of the official solicitation, which is expected to be published in early 2026. For further inquiries, interested parties may contact Dr. Heiyoung Park at Heiyoung.Park@nih.gov or by phone at 301-594-5032.